However, we have been able to observe that strong cellular immune responses (represented by IFN-γ production in whole blood assays) to EBV and CMV antigens in patients with pancreatic cancer post-surgery is concomitant with a survival benefit (Supplementary Figure 2). This evidence concerns the gene IFNG and familial pancreatic carcinoma.